Gerald Falchook - Dissemin

Language
Login

All papers authored by Gerald Falchook

This paper is made freely available by the publisher.

2023 Grace K. Dy

ORCID

, Ramaswamy Govindan

ORCID

, Vamsidhar Velcheti, Gerald S. Falchook

ORCID

, Antoine Italiano

ORCID

ORCID

, Sacher Ag, Adrian G. Sacher, Toshiaki Takahashi

ORCID

, Suresh S. Ramalingam

ORCID

, Christophe Dooms, Dong-Wan Kim

ORCID

, Alfredo Addeo

ORCID

ORCID

, Martin Schuler

ORCID

and 10 other authors

Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated KRAS G12C-Mutated Non–Small-Cell Lung Cancer: 2-Year Analysis of CodeBreaK 100

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Gerald S. Falchook

ORCID

, Jasgit Sachdev

ORCID

, Esteban Rodrigo Imedio

ORCID

, Sanjeev Kumar, Ganesh M. Mugundu, Suzanne Jenkins, Juliann Chmielecki, Suzanne Jones

ORCID

, David R. Spigel, Melissa Johnson

ORCID

A phase Ib study of adavosertib, a selective Wee1 inhibitor, in patients with locally advanced or metastatic solid tumors

Upload

This paper was not found in any repository, but could be made available legally by the author.

2022 Emerson A. Lim

ORCID

, Johanna C. Bendell

ORCID

, Gerald S. Falchook

ORCID

, Todd M. Bauer

ORCID

, Charles G. Drake

ORCID

, Jennifer H. Choe

ORCID

, Daniel J. George

ORCID

, Janet L. Karlix

ORCID

, Susanna Ulahannan

ORCID

, Kris F. Sachsenmeier

ORCID

, Deanna L. Russell

ORCID

, Ganesh Moorthy

ORCID

, Ben S. Sidders

ORCID

, Elizabeth A. Pilling

ORCID

ORCID

and 5 other authors

Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors

Upload

This paper was not found in any repository, but could be made available legally by the author.

Timothy A. Yap

ORCID

, Justin F. Gainor

ORCID

, Margaret K. Callahan, Gerald S. Falchook

ORCID

, Russell K. Pachynski

ORCID

, Patricia LoRusso, Shivaani Kummar, Geoffrey T. Gibney, Howard A. Burris, Scott S. Tykodi

ORCID

, Osama E. Rahma, Tanguy Y. Seiwert, Kyriakos P. Papadopoulos

ORCID

, Mariela Blum Murphy, Haeseong Park

ORCID

and 19 other authors

First-in-Human Phase I/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of Response

Upload

Missing publications? Search for publications with a matching author name.